More News


  • 22-October-2018

    English

    Assessing the economic valuation of the benefits of regulating chemicals - Environment Working Paper

    This paper reviews and compares five case studies on quantification and economic valuation of benefits in cost-benefit analyses (CBAs) of regulating phthalates, mercury, PFOA (perfluoro-octanic acid) and its salts, NMP (1 methyl-2-pyrroloidine) and formaldehyde. The case studies had all been carried out as part of the SACAME project, and the purpose of the present paper is to draw out cross-cutting findings from these studies.

    Related Documents
  • 17-October-2018

    English

    Webinar: Toward greener water and oil repellents in the textile industry - case study

    The webinar will present the MIDWOR-LIFE project that aims to mitigate the environmental, health and safety impacts of current Durable Water and Oil Repellents and available alternatives by looking at their environmental impact and technical performance.

    Related Documents
  • 10-October-2018

    English

    The OECD QSAR Toolbox

    A patch for QSAR Toolbox version 4.2 was released to fix several bugs. It is a minor update to version 4.2 and can be installed as a separate product or alternatively version 4.2 can be updated to version 4.2.1 using the provided patch.

    Related Documents
  • 21-September-2018

    English

    Integrated Approaches to Testing and Assessment (IATA)

    The four new cases includes aspects regarding use of IATA for prioritisation and consideration of the properties of nanomaterials for read-across as well as learning on the application of read-across for repeated dose toxicity.

    Related Documents
  • 12-September-2018

    English

    Webinar: Best Environmental Practices (BEP) for textiles in the context of management of per- and polyfluoroalkyl Substances (PFASs)

    Join us for our per- and polyfluoroalkyl substances webinar on Best Environmental Practices (BEP) for Textiles

    Related Documents
  • 4-September-2018

    English

    Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption

    This guidance document was originally published in 2012 and updated in 2018 to reflect new and updated OECD test guidelines, as well as reflect on scientific advances in the use of test methods and assessment of the endocrine activity of chemicals. The document is intended to provide guidance for evaluating chemical using standardised test guidelines.

    Related Documents
  • 4-September-2018

    English

    Guidance Document on Good In Vitro Method Practices (GIVIMP)

    GIVIMP aims to reduce the uncertainties in cell and tissue-based in vitro method derived predictions by applying good scientific, technical and quality practices from method development to implementation for regulatory use. Test method developers and test guideline users will find best practices for designing guideline in vitro methods, carrying out safety tests and assuring quality and scientific integrity of the resulting data

    Related Documents
  • 31-July-2018

    English

    Call for data on per- and polyfluoroalkyl substances (PFASs) and alternatives

    The OECD is aiming to collect data for a new report on PFASs and Alternatives - Commercial Availability and Current Uses. A questionnaire is available to provide information on current uses of alternatives to PFASs on the following sectors: textile and shoes, firefighting foam and food packaging. Industry, public authorities, NGOs and academia are invited to participate. Please note that the deadline for response is 31 July 2018.

    Related Documents
  • 5-July-2018

    English

    Chemical Safety and Biotechnology News

    This Chemical Safety and Biosafety news release provides an update on the recent projects, events and publications.

    Related Documents
  • 28-June-2018

    English

    Genome Editing: Applications in Agriculture

    The OECD Conference on Genome Editing: Applications in Agriculture – Implications for Health, Environment and Regulation will explore the regulatory considerations raised by genome edited products, with the aim to favour a coherent policy approach to facilitate innovation involving genome editing. More information on the programme and the speakers.

    Related Documents
  • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>